ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT NOVEMBER 2024

GOTHENBURG, Sweden, Dec. 4, 2024 /PRNewswire/ -- Zinzino group revenue increased with a total of 26 %, compared with the previous year. 

The revenue in November for Zinzino's sales markets increased by 26 % and amounted to SEK 252.7 (201.1) million. Faun Pharma's external sales increased by 33 % and amounted to SEK 10.0 (7.5) million. Overall, the Group increased revenues by 26 % to SEK 262.7 (208.6) million compared with the previous year.

Accumulated revenue for January – November 2024 increased by 21 % to SEK 1955.9 (1611.0) million.

Revenues were distributed as follows:

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, www.zinzino.com

Pictures for publication free of charge: [email protected]

Certified Adviser: Carnegie Investment Bank AB (publ.)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-november-2024,c4075440

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-november-2024-302322186.html